Abstract
Coronavirus disease 19 (COVID-19) had a major impact on the number of transplantation procedures worldwide. The severity of COVID-19 infection in Kidney transplant (KT) recipients ranged from mild disease to severe pneumonia and multi-organ failure. The mortality rate is estimated around 30% and risk factors such as old age, comorbid conditions and critical care admission are associated with worse prognosis. There is no optimal therapy for severe COVID-19 infection in such high risk patients and current data reported variable outcomes with different therapeutic options experimented.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
